Loading...
Loading...
Shares of
Esperion Therapeutics IncESPR surged higher by more than 13 percent on Wednesday after the company's director, Gilbert Omenn,
disclosed an insider purchase of 5,000 shares of company stock.
Omenn disclosed in a regulatory filing he bought 5,000 shares of Esperion's stock on Tuesday at a price of $15.28.
While the director's purchase isn't particularly significant in terms of size, several users on Twitter viewed the purchase as a bullish indicator.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in